The table below shows Elevance Health, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Operating cash flow
$4.33B
-
-
-
$1.02B
-
Capital expenditure
$235.00M
-
-
-
$196.00M
-
Investing cash flow
-$1.64B
-
-
-
$103.00M
-
Dividends paid
$376.00M
$377.00M
$376.00M
$385.00M
$386.00M
$373.00M
ELV operating cash flow (10-K history)
Elevance Health, Inc. reported operating cash flow of $4.29B for fiscal year 2025. That is down 26.1% from $5.81B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $3.27B (FY 2016) to $4.29B. Figures come from the company's audited annual reports as filed with the SEC.
